CN114075506A - Urine exosome extraction reagent tube and manufacturing method thereof - Google Patents
Urine exosome extraction reagent tube and manufacturing method thereof Download PDFInfo
- Publication number
- CN114075506A CN114075506A CN202010848912.XA CN202010848912A CN114075506A CN 114075506 A CN114075506 A CN 114075506A CN 202010848912 A CN202010848912 A CN 202010848912A CN 114075506 A CN114075506 A CN 114075506A
- Authority
- CN
- China
- Prior art keywords
- nanofiber membrane
- chitosan
- tube
- urine
- inner tube
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000001808 exosome Anatomy 0.000 title claims abstract description 44
- 210000002700 urine Anatomy 0.000 title claims abstract description 26
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 20
- 238000000605 extraction Methods 0.000 title claims abstract description 19
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 10
- 239000012528 membrane Substances 0.000 claims abstract description 46
- 239000002121 nanofiber Substances 0.000 claims abstract description 35
- 238000000034 method Methods 0.000 claims abstract description 18
- 238000006243 chemical reaction Methods 0.000 claims abstract description 6
- 229920001661 Chitosan Polymers 0.000 claims description 22
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 claims description 19
- 229920001432 poly(L-lactide) Polymers 0.000 claims description 19
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 15
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- RLSSMJSEOOYNOY-UHFFFAOYSA-N m-cresol Chemical compound CC1=CC=CC(O)=C1 RLSSMJSEOOYNOY-UHFFFAOYSA-N 0.000 claims description 12
- 239000000243 solution Substances 0.000 claims description 9
- 239000007864 aqueous solution Substances 0.000 claims description 6
- 125000002091 cationic group Chemical group 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 239000011259 mixed solution Substances 0.000 claims description 6
- 229920002401 polyacrylamide Polymers 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- GRONZTPUWOOUFQ-UHFFFAOYSA-M sodium;methanol;hydroxide Chemical compound [OH-].[Na+].OC GRONZTPUWOOUFQ-UHFFFAOYSA-M 0.000 claims description 4
- RHQDFWAXVIIEBN-UHFFFAOYSA-N Trifluoroethanol Chemical compound OCC(F)(F)F RHQDFWAXVIIEBN-UHFFFAOYSA-N 0.000 claims description 3
- 238000004132 cross linking Methods 0.000 claims description 3
- 239000008367 deionised water Substances 0.000 claims description 3
- 229910021641 deionized water Inorganic materials 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 230000001678 irradiating effect Effects 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 239000012046 mixed solvent Substances 0.000 claims description 3
- 229920000515 polycarbonate Polymers 0.000 claims description 3
- 239000004417 polycarbonate Substances 0.000 claims description 3
- 238000002791 soaking Methods 0.000 claims description 3
- 239000002245 particle Substances 0.000 abstract description 14
- 102000004895 Lipoproteins Human genes 0.000 abstract description 4
- 108090001030 Lipoproteins Proteins 0.000 abstract description 4
- 239000011148 porous material Substances 0.000 abstract description 3
- 238000000926 separation method Methods 0.000 abstract description 3
- 239000011324 bead Substances 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 4
- 238000000703 high-speed centrifugation Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000008055 phosphate buffer solution Substances 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000007717 exclusion Effects 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 108020005198 Long Noncoding RNA Proteins 0.000 description 1
- 108700011259 MicroRNAs Proteins 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000006023 anti-tumor response Effects 0.000 description 1
- 230000030741 antigen processing and presentation Effects 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000009400 cancer invasion Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- -1 circRNA Proteins 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 239000002679 microRNA Substances 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 238000001542 size-exclusion chromatography Methods 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 210000001138 tear Anatomy 0.000 description 1
- 238000001926 trapping method Methods 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 238000005199 ultracentrifugation Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/02—Form or structure of the vessel
- C12M23/06—Tubular
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M33/00—Means for introduction, transport, positioning, extraction, harvesting, peeling or sampling of biological material in or from the apparatus
- C12M33/10—Means for introduction, transport, positioning, extraction, harvesting, peeling or sampling of biological material in or from the apparatus by centrifugation ; Cyclones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M33/00—Means for introduction, transport, positioning, extraction, harvesting, peeling or sampling of biological material in or from the apparatus
- C12M33/14—Means for introduction, transport, positioning, extraction, harvesting, peeling or sampling of biological material in or from the apparatus with filters, sieves or membranes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
- C12M47/04—Cell isolation or sorting
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F8/00—Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof
- D01F8/04—Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof from synthetic polymers
- D01F8/14—Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof from synthetic polymers with at least one polyester as constituent
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F8/00—Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof
- D01F8/18—Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof from other substances
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M10/00—Physical treatment of fibres, threads, yarns, fabrics, or fibrous goods made from such materials, e.g. ultrasonic, corona discharge, irradiation, electric currents, or magnetic fields; Physical treatment combined with treatment with chemical compounds or elements
- D06M10/001—Treatment with visible light, infrared or ultraviolet, X-rays
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M10/00—Physical treatment of fibres, threads, yarns, fabrics, or fibrous goods made from such materials, e.g. ultrasonic, corona discharge, irradiation, electric currents, or magnetic fields; Physical treatment combined with treatment with chemical compounds or elements
- D06M10/04—Physical treatment combined with treatment with chemical compounds or elements
- D06M10/08—Organic compounds
- D06M10/10—Macromolecular compounds
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M15/00—Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment
- D06M15/19—Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment with synthetic macromolecular compounds
- D06M15/21—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
- D06M15/285—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds of unsaturated carboxylic acid amides or imides
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M2101/00—Chemical constitution of the fibres, threads, yarns, fabrics or fibrous goods made from such materials, to be treated
- D06M2101/02—Natural fibres, other than mineral fibres
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M2101/00—Chemical constitution of the fibres, threads, yarns, fabrics or fibrous goods made from such materials, to be treated
- D06M2101/16—Synthetic fibres, other than mineral fibres
- D06M2101/30—Synthetic polymers consisting of macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- D06M2101/32—Polyesters
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Textile Engineering (AREA)
- Sustainable Development (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Clinical Laboratory Science (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses a urine exosome extraction reagent tube and a manufacturing method thereof. The invention can complete the whole reaction in a short time without waiting for a long time; by using the positive and negative charge attraction principle, the method not only has no pollution of a separation reagent, but also can remove uncharged lipoprotein with the particle size of 50-200nm in urine; the pore size on the positive charge porous nanofiber membrane is about 50-200nm, so that exosomes with high purity and particle size of 50-200nm can be obtained, and pollution of microvesicles with other particle sizes is prevented; the porous structure on the positive charge porous nanofiber membrane greatly improves the contact area between the membrane and a sample, and increases the extraction efficiency of urine exosomes.
Description
Technical Field
The invention relates to the technical field of exosome extraction, in particular to a urine exosome extraction reagent tube and a manufacturing method thereof.
Background
Exosomes were first found in 1981, and membrane-structured vesicles were found in supernatants of sheep erythrocytes cultured in vitro by EGTrams et al, and were named exosomes. For the action of exosomes, it was speculated at that time as a way for cells to excrete waste. In 1996, GRaposo et al found that immune cells similar to B lymphocytes also secreted antigen presenting exosomes (antigen presenting exosomes) that directly stimulated the anti-tumor response of effector CD4+ cells. HValadi et al further discovered in 2007 that genetic material could be exchanged between cells via RNA in exosomes. With the increasing research on exosomes, researchers find that it is widely involved in various biological processes such as immune response, antigen presentation, cell differentiation, tumor growth and invasion.
Almost all types of cells secrete exosomes, and exosomes are also widely present in body fluids, including blood, tears, urine, saliva, milk, ascites, and the like. Nucleic acid (microRNA, lncRNA, circRNA, mRNA, tRNA and the like), protein, cholesterol and other substances carried by exosome can be effectively wrapped by an exosome double-layer membrane, so that the exosome can resist the degradation of various factors, and can stably exist in body fluid.
At the present stage, urine exosomes are mainly extracted by an ultra-high speed centrifugation method, a magnetic bead antibody capture method, a hue column size exclusion method, a PEG precipitation column passing method and a positive charge capture method. Ultra-high speed centrifugation: ultracentrifugation is the most common purification method for exosome at present, and vesicles of the same size are precipitated and purified from a sample by high-speed centrifugation. The pellet (containing exosomes) was centrifuged at 100,000-. Magnetic bead antibody capture method: phosphoesterylserine (PS) on the exosome membrane specifically binds to the Tim4 anchored magnetic beads, and is separated by elution buffer containing EDTA. Size exclusion chromatography on chromatography column: exosomes are separated from other particle size proteins according to their particle size. PEG precipitation column-passing method: the exosomes were precipitated by PEG, removed by ion column and finally eluted with high salt solution. Positive charge trapping method: and covering a positively charged coating on the solid phase carrier, and capturing the negatively charged exosomes through positive and negative charge attraction.
The existing exosome technology is time-consuming (40min-10 hours are different), the extraction reagents are polluted to different degrees (such as residual precipitating reagents in a PEG precipitation method, such as residual high-salt reagents in a column passing method, such as pollution of magnetic bead anchor chain antibodies in a magnetic bead adsorption method and pollution of eluent EDTA), positive charge capture does not cause pollution of the extraction reagents, but cannot distinguish microvesicles with the particle size of more than 200nm from exosomes with the particle size of 50-200nm, the extraction efficiency of urine exosomes by a hue column size exclusion method is low, a large amount of macromolecular substances contained in urine easily block a hue column, and the urine is easily polluted by lipoprotein with the particle size of about 100 nm.
Disclosure of Invention
The technical problem to be solved by the present invention is to overcome the defects of the prior art and to provide a urine exosome extraction reagent tube, and another object of the present invention is to provide a manufacturing method for manufacturing the urine exosome extraction reagent tube.
In order to solve the technical problems, the invention provides the following technical scheme:
the invention relates to a urine exosome extraction reagent tube which comprises a cap, an outer tube and an inner tube, wherein the cap is sleeved on the top end surface of the outer tube in a threaded manner, the inner tube is sleeved inside the outer tube, and a nanofiber membrane is arranged on the inner wall of the inner tube.
As a preferable technical scheme of the invention, the outer walls of the outer pipe and the inner pipe are both provided with capacity scale marks, and the outer pipe and the inner pipe are both made of polycarbonate materials.
The invention provides a preparation method for preparing the urine exosome extraction reagent tube, which comprises the following preparation steps:
a: dissolving PLLA with the molecular weight of 9 ten thousand and chitosan in trifluoroethanol solution according to the proportion of 5:1 to prepare mixed solution with the concentration of 8 wt%, and fully dissolving the mixed solution of the PLLA and the chitosan at the room temperature of 25-30 ℃;
b: pushing the injector with a 27g needle at a speed of 0.5-1.0 ml/h under a high voltage of 8-10kV, and receiving the nanofiber membrane with a standing plane;
c: putting the nanofiber membrane into a mixed solvent of ethanol and m-cresol, dissolving and removing for 60min at the room temperature of 25-30 ℃, and drying;
d: soaking the membrane in 1.5mol/L sodium hydroxide methanol aqueous solution for 30min to obtain porous PLLA/chitosan nanofiber membrane;
e: adding 50mg of cationic polyacrylamide into 100ml of deionized water, heating to 50 ℃, stirring, adjusting the pH value of a solution to be 7.0 by using NaOH, immersing the porous PLLA/chitosan nanofiber membrane into the solution, stirring for 24 hours at the room temperature of 25-30 ℃, and drying;
f: irradiating for 3 hours by using an ultraviolet lamp, and performing crosslinking reaction on the cationic polyacrylamide and chitosan to obtain a porous PLLA/chitosan nanofiber membrane with positive charges;
g: and adhering the positive charge porous PLLA/chitosan nanofiber membrane on the inner wall of the inner tube, combining the inner tube 3 and the outer tube, and screwing the cap on the inner tube.
In the above production method, the ratio of ethanol to m-cresol in step C is 1: 1.
In the above manufacturing method, the ratio of methanol to water in the aqueous solution of sodium hydroxide and methanol in step D is 1: 1.
Compared with the prior art, the invention has the following beneficial effects:
the invention can complete the whole reaction in a short time without waiting for a long time; by using the positive and negative charge attraction principle, the method not only has no pollution of a separation reagent, but also can remove uncharged lipoprotein with the particle size of 50-200nm in urine; the pore size on the positive charge porous nanofiber membrane is about 50-200nm, so that exosomes with high purity and particle size of 50-200nm can be obtained, and pollution of microvesicles with other particle sizes is prevented; the porous structure on the positive charge porous nanofiber membrane greatly improves the contact area between the membrane and a sample, and increases the extraction efficiency of urine exosomes.
Drawings
The accompanying drawings, which are included to provide a further understanding of the invention and are incorporated in and constitute a part of this specification, illustrate embodiments of the invention and together with the description serve to explain the principles of the invention and not to limit the invention. In the drawings:
FIG. 1 is a schematic view of the overall structure of the present invention;
FIG. 2 is a cross-sectional view of the structure of FIG. 1;
FIG. 3 is a flow chart of the positively charged porous PLLA/chitosan nanofiber membrane fabrication of the present invention;
FIG. 4 is a flow chart of urine exosome extraction of the present invention;
in the figure: 1. capping; 2. an outer tube; 3. an inner tube; 4. a nanofiber membrane.
Detailed Description
The preferred embodiments of the present invention will be described in conjunction with the accompanying drawings, and it will be understood that they are described herein for the purpose of illustration and explanation and not limitation.
Example 1
As shown in fig. 1 to 4, the invention provides a urine exosome extraction reagent tube, which comprises a cap 1, an outer tube 2 and an inner tube 3, wherein the cap 1 is sleeved on the top end surface of the outer tube 2 in a threaded manner, the inner tube 3 is sleeved inside the outer tube 2, and a nanofiber membrane 4 is arranged on the inner wall of the inner tube 3.
The outer walls of the outer pipe 2 and the inner pipe 3 are both provided with capacity scale marks, and the outer pipe 2 and the inner pipe 3 are both made of polycarbonate materials.
The preparation method of the urine exosome extraction reagent tube comprises the following steps:
a: dissolving PLLA with the molecular weight of 9 ten thousand and chitosan in trifluoroethanol solution according to the proportion of 5:1 to prepare mixed solution with the concentration of 8 wt%, and fully dissolving the mixed solution of the PLLA and the chitosan at the room temperature of 25-30 ℃;
b: pushing the injector with a 27g needle at a speed of 0.5-1.0 ml/h under a high voltage of 8-10kV, and receiving the nanofiber membrane with a standing plane;
c: putting the nanofiber membrane into a mixed solvent of ethanol and m-cresol, dissolving and removing for 60min at the room temperature of 25-30 ℃, and drying;
d: soaking the membrane in 1.5mol/L sodium hydroxide methanol aqueous solution for 30min to obtain porous PLLA/chitosan nanofiber membrane;
e: adding 50mg of cationic polyacrylamide into 100ml of deionized water, heating to 50 ℃, stirring, adjusting the pH value of a solution to be 7.0 by using NaOH, immersing the porous PLLA/chitosan nanofiber membrane into the solution, stirring for 24 hours at the room temperature of 25-30 ℃, and drying;
f: irradiating for 3 hours by using an ultraviolet lamp, and performing crosslinking reaction on the cationic polyacrylamide and chitosan to obtain a porous PLLA/chitosan nanofiber membrane with positive charges;
g: adhering the positive charge porous PLLA/chitosan nanofiber membrane on the inner wall of the inner tube 3, combining the inner tube 3 and the outer tube 2, and screwing the cap 1.
Further, the ratio of ethanol to m-cresol in step C was 1: 1.
In step D, the ratio of methanol to water in the sodium hydroxide methanol aqueous solution is 1: 1.
Specifically, the nanofiber membrane 4 on the inner wall of the inner tube 3 is a positive charge porous nanofiber membrane, when the nanofiber membrane is used, 5ml of phosphate buffer solution is firstly used for washing the nanofiber membrane 4 once, 10ml of urine is sprayed on the nanofiber membrane 4 to cover the cap 1, centrifugation is carried out for 1min at the rotating speed of 1000rpm to remove waste liquid, 500ul of phosphate buffer solution is added for lightly washing the membrane once, washing liquid is sucked and discarded to remove micro-capsule components which are adhered to the membrane and are larger than 200nm, finally 500ul of phosphate buffer solution is added for repeatedly washing the nanofiber membrane for 4 times, centrifugation is carried out for 1min at the rotating speed of 1000rpm, and membrane washing liquid (exosomes with the diameter of 50-200 nm) is collected.
The invention can complete the whole reaction in a short time without waiting for a long time; by using the positive and negative charge attraction principle, the method not only has no pollution of a separation reagent, but also can remove uncharged lipoprotein with the particle size of 50-200nm in urine; the pore size on the positive charge porous nanofiber membrane is about 50-200nm, so that exosomes with high purity and particle size of 50-200nm can be obtained, and pollution of microvesicles with other particle sizes is prevented; the porous structure on the positive charge porous nanofiber membrane greatly improves the contact area between the membrane and a sample, and increases the extraction efficiency of urine exosomes.
Finally, it should be noted that: although the present invention has been described in detail with reference to the foregoing embodiments, it will be apparent to those skilled in the art that changes may be made in the embodiments and/or equivalents thereof without departing from the spirit and scope of the invention. Any modification, equivalent replacement, or improvement made within the spirit and principle of the present invention should be included in the protection scope of the present invention.
Claims (5)
1. The utility model provides a urine exosome draws reagent pipe, includes cap (1), outer tube (2) and inner tube (3), cap (1) has been cup jointed to the top surface screw thread of outer tube (2), inner tube (3) have been cup jointed to the inside of outer tube (2), its characterized in that, the inner wall of inner tube (3) is provided with nanofiber membrane (4).
2. The urine exosome extraction reagent tube and the manufacturing method thereof according to claim 1, characterized in that the outer walls of the outer tube (2) and the inner tube (3) are provided with capacity scale marks, and the outer tube (2) and the inner tube (3) are made of polycarbonate materials.
3. The method for preparing a reagent tube for extracting urine exosomes according to claim 1, which comprises the following steps:
a: dissolving PLLA with the molecular weight of 9 ten thousand and chitosan in trifluoroethanol solution according to the proportion of 5:1 to prepare mixed solution with the concentration of 8 wt%, and fully dissolving the mixed solution of the PLLA and the chitosan at the room temperature of 25-30 ℃;
b: pushing the injector with a 27g needle at a speed of 0.5-1.0 ml/h under a high voltage of 8-10kV, and receiving the nanofiber membrane with a standing plane;
c: putting the nanofiber membrane into a mixed solvent of ethanol and m-cresol, dissolving and removing for 60min at the room temperature of 25-30 ℃, and drying;
d: soaking the membrane in 1.5mol/L sodium hydroxide methanol aqueous solution for 30min to obtain porous PLLA/chitosan nanofiber membrane;
e: adding 50mg of cationic polyacrylamide into 100ml of deionized water, heating to 50 ℃, stirring, adjusting the pH value of a solution to be 7.0 by using NaOH, immersing the porous PLLA/chitosan nanofiber membrane into the solution, stirring for 24 hours at the room temperature of 25-30 ℃, and drying;
f: irradiating for 3 hours by using an ultraviolet lamp, and performing crosslinking reaction on the cationic polyacrylamide and chitosan to obtain a porous PLLA/chitosan nanofiber membrane with positive charges;
g: and (3) adhering the positive charge porous PLLA/chitosan nanofiber membrane to the inner wall of the inner tube (3), combining the inner tube (3) and the outer tube (2), and screwing the cap (1).
4. The method as claimed in claim 3, wherein the ratio of ethanol to m-cresol in step C is 1: 1.
5. The method as claimed in claim 3, wherein the ratio of methanol to water in the aqueous solution of NaOH in methanol in step D is 1: 1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010848912.XA CN114075506B (en) | 2020-08-21 | 2020-08-21 | Urine exosome extraction reagent tube and manufacturing method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010848912.XA CN114075506B (en) | 2020-08-21 | 2020-08-21 | Urine exosome extraction reagent tube and manufacturing method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114075506A true CN114075506A (en) | 2022-02-22 |
CN114075506B CN114075506B (en) | 2023-11-17 |
Family
ID=80282373
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010848912.XA Active CN114075506B (en) | 2020-08-21 | 2020-08-21 | Urine exosome extraction reagent tube and manufacturing method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114075506B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115786107A (en) * | 2022-12-14 | 2023-03-14 | 深圳市寰宇生物科技有限公司 | Efficient preparation device and method for exosome |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106283396A (en) * | 2016-08-22 | 2017-01-04 | 王利萍 | A kind of preparation method of porous chitosan fibrous membrane |
CN107254430A (en) * | 2017-08-11 | 2017-10-17 | 上海浦美生物医药科技有限公司 | A kind of method based on positive charge adsorbing separation excretion body |
CN209485829U (en) * | 2018-08-16 | 2019-10-11 | 南方医科大学 | The device of the workable enrichment urine excretion body of hospital and family |
-
2020
- 2020-08-21 CN CN202010848912.XA patent/CN114075506B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106283396A (en) * | 2016-08-22 | 2017-01-04 | 王利萍 | A kind of preparation method of porous chitosan fibrous membrane |
CN107254430A (en) * | 2017-08-11 | 2017-10-17 | 上海浦美生物医药科技有限公司 | A kind of method based on positive charge adsorbing separation excretion body |
CN209485829U (en) * | 2018-08-16 | 2019-10-11 | 南方医科大学 | The device of the workable enrichment urine excretion body of hospital and family |
Non-Patent Citations (2)
Title |
---|
FATEMEH BARATI1: "A promising approach toward efficient isolation of the exosomes by core–shell PCL‑gelatin electrospun nanofibers", BIOPROCESS AND BIOSYSTEMS ENGINEERING * |
PRATEEK SINGH ET AL: "Novel label-free method for extracellular-vesicle enrichment from biological fluids and cell culture medium", ISEV2018 ABSTRACT BOOK,,JOURNAL OF EXTRACELLULAR VESICLES, pages 223 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115786107A (en) * | 2022-12-14 | 2023-03-14 | 深圳市寰宇生物科技有限公司 | Efficient preparation device and method for exosome |
Also Published As
Publication number | Publication date |
---|---|
CN114075506B (en) | 2023-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20220349901A1 (en) | Lectin-macromolecule carrier coupling complex for separating glycosylated exosome in clinical sample | |
US20220372173A1 (en) | Lectin-magnetic carrier coupling complex for separating glycosylated exosomes from clinical sample | |
CN110540961A (en) | annexin V-FITC exosome capture affinity magnetic bead, preparation method thereof and method for extracting exosome by using same | |
CN113101737B (en) | Affinity tangential flow filtration system, construction method thereof, exosome extraction method and application | |
CN109825472A (en) | A kind of extracting method and kit of extracellular vesica | |
CN105792926A (en) | New process and system for magnetic separation | |
CN114540271B (en) | Purification method of plant exosomes | |
US7465579B2 (en) | Device and method for introducing particle into cell and device and method for collecting particle from cell | |
CN112322584A (en) | Simple exosome extraction method | |
CN114075506A (en) | Urine exosome extraction reagent tube and manufacturing method thereof | |
CN108387424B (en) | Preparation method and application of porous silicon material for biological sample pretreatment | |
CN112831457A (en) | Method for separating and concentrating exosome | |
CN107353338B (en) | Method for separating pigment molecules in hirudin fermentation liquor | |
CN112391384A (en) | Kit for rapidly extracting genomic DNA of gram-negative bacteria and extraction method | |
CN112048462A (en) | Extracellular vesicle separation and enrichment method based on anionic polymer modified matrix | |
CN114397388B (en) | Urine exosome extraction kit based on combination of PEG precipitation method and SEC column method and application | |
CN111394307A (en) | Method for separating and purifying exosome from plasma and application | |
CN114891723B (en) | Milk-derived exosome and extraction method | |
CN114164203B (en) | Extracellular vesicle purification material and purification method | |
CN116376124A (en) | Method for rapidly separating and enriching exosomes based on chitosan with specific molecular weight | |
CN115710572A (en) | Preparation method of exosome | |
CN205898536U (en) | Separation and extraction secretes stromatolite centrifugal filtration device of body outward | |
CN110093246B (en) | Multi-pole magnetic field continuous magnetic bead cell separation device and method thereof | |
CN112813027A (en) | Method for separating exosomes in urine | |
CN112125950A (en) | Large-scale production method for protein separation and purification |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |